ProShare Advisors’s Biohaven BHVN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$260K Buy
17,484
+439
+3% +$4.73K ﹤0.01% 1508
2026
Q1
$144K Sell
17,045
-93
-0.5% -$1.02K ﹤0.01% 1654
2025
Q4
$193K Buy
17,138
+1,669
+11% +$20.7K ﹤0.01% 1735
2025
Q3
$232K Sell
15,469
-3,081
-17% -$44.8K ﹤0.01% 1613
2025
Q2
$262K Sell
18,550
-45
-0.2% -$802 ﹤0.01% 1544
2025
Q1
$447K Sell
18,595
-5,594
-23% -$197K ﹤0.01% 1156
2024
Q4
$903K Buy
24,189
+9,999
+70% +$467K ﹤0.01% 961
2024
Q3
$709K Buy
14,190
+5,026
+55% +$196K ﹤0.01% 934
2024
Q2
$318K Sell
9,164
-3,127
-25% -$124K ﹤0.01% 1246
2024
Q1
$672K Buy
12,291
+967
+9% +$47.9K ﹤0.01% 928
2023
Q4
$485K Buy
+11,324
New +$352K ﹤0.01% 1051

Other funds holding BHVN

ProShare Advisors's BHVN Position: Q2 2026 in Review

ProShare Advisors increased its Biohaven (BHVN) stake by 2.6% in Q2 2026, buying an estimated $4.73K and bringing the position to 17,484 shares worth $260K. The position accounts for ﹤0.01% of the portfolio, ranked #1508.

ProShare Advisors first reported a position in BHVN in Q4 2023 and has held it in 11 quarters since. The position peaked at $903K in Q4 2024. 292 funds tracked by Wall St. Rank hold BHVN as of Q2 2026.

  • ProShare Advisors held 17,484 shares of Biohaven worth $260K as of Q2 2026.
  • ProShare Advisors bought 439 Biohaven shares in Q2 2026, an estimated $4.73K.
  • Biohaven made up ﹤0.01% of ProShare Advisors's portfolio in Q2 2026, its #1508 holding.
  • ProShare Advisors first reported a position in Biohaven in Q4 2023 and has held it in 11 quarters since.
  • ProShare Advisors's Biohaven position peaked at $903K in Q4 2024.
  • 292 funds tracked by Wall St. Rank held Biohaven as of Q2 2026.

Based on ProShare Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.